Mar 21 |
Apyx Medical reports mixed Q4 results; initiates FY24 outlook
|
Mar 21 |
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
|
Mar 4 |
Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024
|
Feb 21 |
Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting
|
Feb 8 |
Favourable Signals For Apyx Medical: Numerous Insiders Acquired Stock
|
Jan 22 |
Apyx stock rises on publication of Renuvion safety analysis
|
Jan 22 |
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body
|
Jan 8 |
Apyx Medical's Q4 revenue to be below consensus
|
Jan 8 |
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
|
Dec 14 |
Apyx Medical finance chief buys 2.5K common shares
|